Netherlands· NL-fa80d99f3663
Lutetium (177Lu)-chloride Billev 51,8 GBq/ml radiofarmaceutische precursor, oplossing
A other therapeutic radiopharmaceuticals product containing lutetium [177lu]trichloride, registered in Netherlands by Billev Pharma ApS. The same ATC class is registered in 8 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Lutetium [177lu]trichloride is registered in 8 of 19 countries.
Countries holding a registration under ATC V10X (other therapeutic radiopharmaceuticals), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 5 of them publish a price we can compare per daily dose
Lutetium [177lu]trichloride · ATC V10X
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- LUTETIUM [177Lu]TRICHLORIDE
- Manufacturer
- Billev Pharma ApS
- Country
- Netherlands (NL)
- ATC code
- V10X
- ATC class
- OTHER THERAPEUTIC RADIOPHARMACEUTICALS
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/22/1680
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V10X
Other therapeutic radiopharmaceuticals, as other registers publish it.
- IcelandEndolucinBetaITM Medical Isotopes GmbH
- DenmarkEndolucinBetaITM Medical Isotopes GmbH
- PolandEndolucinBetaITM Medical Isotopes GmbH
- FinlandEndolucinBetaITM Medical Isotopes GmbH
- CzechiaENDOLUCINBETAITM Medical Isotopes GmbH, Garching
- CzechiaENDOLUCINBETAITM Medical Isotopes GmbH, Garching
- BelgiumEndolucinBeta 40 GBq/mlITM Medical Isotopes
- BelgiumEndolucinBeta 40 GBq/mlITM Medical Isotopes
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9827d1c2-e775-43ed-bec3-3120aa73d101 GET /v1/drugs/9827d1c2-e775-43ed-bec3-3120aa73d101?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Radiofarmaceutische uitgangsstof",
"route": "Toedieningsweg niet van toepassing",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/lutetium-177lu-chloride-billev-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Other Therapeutic Radiopharmaceuticals",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp128784",
"excipients": [
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"LUTETIUM [177Lu]TRICHLORIDE"
],
"leaflet_url": null,
"authorised_at": "2022/09/15",
"procedure_number": "EMEA/H/C/005859",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/22/1680",
"additional_monitoring": "N"
}See everything about lutetium [177lu]trichloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.